Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients.
about
KASL clinical practice guidelines: management of chronic hepatitis BPotential mechanisms of hepatitis B virus induced liver injuryClinical utility of hepatitis B surface antigen levels during the natural history and treatment of chronic hepatitis B infectionEfficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study.The role of HBsAg quantification for monitoring natural history and treatment outcome.HBsAg quantification: useful for monitoring natural history and treatment outcome.Hepatitis B surface antigen quantification in chronic hepatitis B and its clinical utility.Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analoguesHepatitis B s antigen kinetics during treatment with nucleos(t)ides analogues in patients with hepatitis B e antigen-negative chronic hepatitis B.High treatment modification rates with lamivudine therapy in HBV-infected patients with low baseline viremia and early virological response: A multicenter study.Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection.Loss of HBsAg and antiviral treatment: from basics to clinical significance.Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers.Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy
P2860
Q26752475-594D6B71-29FF-4FD5-8EFE-85A9148824D8Q27014079-7099A75E-21F8-48EA-8644-CA41E051FDAAQ33947471-5423F6CC-CBD2-41DC-905D-7739102C5EDCQ37138794-09FD61DB-7ACB-4F1B-94DF-EF7C6091C41EQ38071397-9E1E160D-803A-4524-8159-6F6AAAB34AF7Q38174257-1808B1C3-F593-4AD5-B87C-01D6C6DD0684Q38177851-04AB14E8-8843-4FFF-9D66-886CC42138DBQ38224440-C2A5F11B-E550-4AB9-B0F6-C9F5435466A6Q40272794-1E9AA271-F689-4DE7-8140-646A0E4BCFEFQ41467947-CA4E2703-3392-4E63-996B-D2D95E2D79E0Q41982541-EE184202-E254-46F5-A02D-9CB56602E17DQ42235230-F9C47403-DD70-4208-887F-11CD1E789CB6Q42257535-22EF2A63-DA5C-4DD1-8174-9C4FDB13BA99Q58235736-1D0C9EB0-A839-4ED6-B9A5-47B83D5FCC1B
P2860
Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Serum hepatitis B surface anti ...... ed hepatitis B virus patients.
@en
Serum hepatitis B surface anti ...... ed hepatitis B virus patients.
@nl
type
label
Serum hepatitis B surface anti ...... ed hepatitis B virus patients.
@en
Serum hepatitis B surface anti ...... ed hepatitis B virus patients.
@nl
prefLabel
Serum hepatitis B surface anti ...... ed hepatitis B virus patients.
@en
Serum hepatitis B surface anti ...... ed hepatitis B virus patients.
@nl
P2093
P2860
P1476
Serum hepatitis B surface anti ...... ed hepatitis B virus patients.
@en
P2093
A Gramenzi
M Bernardi
P Andreone
P2860
P304
P356
10.1111/J.1365-2893.2011.01473.X
P577
2011-06-01T00:00:00Z